ConductScience.org, home

Paper2159442

The use of a genotypic marker to demonstrate clonal dominance during the growth and metastasis of a human breast carcinoma in nude mice.

Price JE and 2 others. Int J Cancer, 1990. Cited by 29 papers, by iCite.

Cite this record

ConductScience Library. The use of a genotypic marker to demonstrate clonal dominance during the growth and metastasis of a human breast carcinoma in nude mice. Papers, record 2159442. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2159442

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The use of a genotypic marker to demonstrate clonal dominance during the growth and metastasis of a human breast carcinoma in nude mice.
PubMed
Journal
Int J Cancer
PubMed
Year
1990
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
29
iCite
Relative citation ratio, by iCite
0.82
iCite
Revised in PubMed
2019-07-08
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Price JEJ E
2Bell CC
3Frost PP

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Animals
Cell Division
Cell Line
Clone Cells
DNA Transposable Elements
DNA, Bacterial
DNA, Neoplasm
Drug Resistance, Microbial
Female
Genetic Markers
Genotype
Humans
Mice
Mice, Nude
Neomycin
Neoplasm Metastasis
Neoplasm Transplantation
Plasmids
Transfection
Transplantation, Heterologous

Source PubMed

Download CSV of topics

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.

PMIDTitleJournalYearIn PapersSource
26729788Tumor Heterogeneity--A 'Contemporary Concept' Founded on Historical Insights and Predictions.Cancer Res2016https://conductscience.org/library/papers/26729788PubMed
18337506Comparative lesion sequencing provides insights into tumor evolution.Proc Natl Acad Sci U S A2008https://conductscience.org/library/papers/18337506PubMed
18071912Clonal diversity in carcinomas: its implications for tumour progression and the contribution made to it by epithelial-mesenchymal transitions.Clin Exp Metastasis2008https://conductscience.org/library/papers/18071912PubMed
17260103
Isolation of a human gallbladder cancer cell clone with high invasive phenotype in vitro and metastatic potential in orthotopic model and inhibition of its invasiveness by heparanase antisense oligodeoxynucleotides.
Clin Exp Metastasis2007https://conductscience.org/library/papers/17260103PubMed
12854146Expression of proliferating cell nuclear antigen and CD44 variant exon 6 in primary tumors and corresponding lymph node metastases of colorectal carcinoma with Dukes' stage C or D.World J Gastroenterol2003https://conductscience.org/library/papers/12854146PubMed
11819844Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97.World J Gastroenterol2001https://conductscience.org/library/papers/11819844PubMed
10763921Characterization of spontaneous metastasis in an aggressive breast carcinoma model using flow cytometry.Clin Exp Metastasis1999https://conductscience.org/library/papers/10763921PubMed
8518409Growth and metastasis of human breast carcinomas with Matrigel in athymic mice.Breast Cancer Res Treat1993https://conductscience.org/library/papers/8518409PubMed
8435480The nude mouse as an in vivo model for human breast cancer invasion and metastasis.Breast Cancer Res Treat1993https://conductscience.org/library/papers/8435480PubMed
8407718Growth advantage ("clonal dominance") of metastatically competent tumor cell variants expressed under selective two- or three-dimensional tissue culture conditions.In Vitro Cell Dev Biol Anim1993https://conductscience.org/library/papers/8407718PubMed
8287617Clonal dominance detected in metastases but not primary tumors of retrovirally marked human breast carcinoma injected into nude mice.Clin Exp Metastasis1994https://conductscience.org/library/papers/8287617PubMed
7820953Growth and metastasis of human breast cancers in athymic nude mice.Clin Exp Metastasis1995https://conductscience.org/library/papers/7820953PubMed
1676353Human lung adenocarcinoma cell lines with different lung colonization potential (LCP), and a correlation between expression of sialosyl dimeric Le(x) (defined by MAb FH6) and LCP.Clin Exp Metastasis1991https://conductscience.org/library/papers/1676353PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2159442

GET https://conductscience.org/api/papers/v1/2159442/authors